addition, bone marrow (BM) cells that harbor T and NK precursors are able to generate cytolytic a~tivity,'~.'' but the characteristics of the effector cells are unclear.
Although both NK and T cells are able to generate LAK activity, their activation requirements are different. NK cells are activated merely by IL-2, and accessory cells or additional factors are apparently not r e q~i r e d .~. '~ Conversely, purified peripheral blood T cells do not develop LAK function when cultured with IL-2 alone,8," having a strict requirement for accessory cells for the development of lytic a~t i v i t y . "~'~~'~ Many studies have also shown that the generation of cytotoxic T lymphocytes (CTL) from resting BM precursors or thymocytes requires both IL-2 and a soluble factor that is present in the supernatants of Con-A or PHA-activated T cells, and is distinct from IL-2.20-22 Takatsu et al" demonstrated that IL-S/BCGF-2, a T-cell-derived B-cell differentiation factor, also induced CTL in the presence of IL-2.
We recently reported that LMW-BCGF (12 Kd), purified from lectin-stimulated peripheral blood mononuclear cellconditioned medium,24 plus recomhinant IL-2 (rIL-2) synergistically induced the expansion of CD3 + cells accompanied by LAK activity from the BM cells of children with acute lymphoblastic leukemia (ALL).25 To investigate whether this LAK activity was mediated by the expanded CD3+ T cells or by CD3-NK cells that were simultaneously generated by the combined lymphokines, the antigenic phenotype and lytic activity of the generated cells were further analyzed in this study.
MATERIALS AND METHODS

Patient material.
Ten pediatric patients (under 18 years of age) with non-T, non-B ALL who were treated at Emory University (Atlanta, GA) were included in this study. Informed consent was obtained according to institutional guidelines. Six patients had active disease (diagnosis N = 2, relapse N = 4), and four patients were in complete remission (CR). After informed consent was obtained, BM cells were aspirated from the iliac crest. The diagnosis of leukemia was based on the French-American-British cooperative group designation and the surface marker profiles of the leukemic blasts (as determined by standard methods of immunophenotyping and flow cytometry). Selected clinical and immunologic data of the patients entered into this study are summarized in Table 1 .
BM mononuclear cells were isolated by centrifugation on Ficoll-Hypaque (1.077 g/mL). In all cases monocytes were removed by adherence to plastic Petri dishes in which BM cells were incubated at 37OC for 1 hour, and mature CD3 + T lymphocytes were depleted by an immunomagnetic separation CD3-cells (106/mL) were suspended in RPMI 1640 containing rIL-2 (100 U/mL) (Amgen, Thousand Oaks, CA) and/or low molecular weight B-cell growth factor (LMW-BCGF) (0.1 U/mL) (Cellular Product Inc, Buffalo, NY), and incubated in tissue culture flasks. Cells were counted every 2 to 4 days and refed with fresh medium, rIL-2, and/or LMW-BCGF. Cell concentration was readjusted to 106/mL. Cultures were kept in 5% C 0 2 at 37OC. After 7 to 14 days, cells were harvested for surfacemarker determination and separation.
Immunomagnetic bead separation. CD3+ cells and Leu 19+ cells were positively selected by use of immunomagnetic beads." Cells that expanded in BM culture with rIL-2 plus LMW-BCGF were divided into two parts and pelleted by centrifugation in two tubes. Cells in each were mixed with anti-CD3 and anti-Leu 19 antibodies, respectively. The mixture was incubated at 2 to 8OC for 30 minutes and washed twice. Cells treated with the primary antibodies were then incubated with immunomagnetic beads coated with sheep anti-mouse immunoglobulin G (Dynabeads M-450, Dynal AS, Oslo, Norway) for 30 minutes at 2 to 8OC. The immunobeads-to-target cell ratio was 7.5:1 for positive selection. Isolation was performed by adding 5 mL of cold culture medium and placing the culture tube in a specially designed magnet (Dynal) for 1 to 2 minutes. During this time, the CD3+ and Leu 19+ cells (rosetted with beads) were attracted to the wall of the test tubes by the magnetic field. The rosette-free cell-suspension was decanted. The rosette-positive fraction was washed 2 or 3 times by the above procedure, resuspended in RPMI, and incubated at 37OC in 5% CO, for 16 to 20 hours. Then CD3+ and Leu 19+ cells were separated from beads.
Next, purified CD3+ and Leu 19+ cells were further separated by the above procedure. At this time, anti-Leu 19 antibody was Preparation of cells with LAK activity.
added to CD3 + cells, and anti-CD3 antibody was added to Leu 19+ cells. The beads-to-target cell ratio was 201. Finally, three subsets ofLAKcells(CD3+/Leu 19-,CD3+/Leu 19+,andCD3-/Leu 19+) were obtained. The purity of separated cells in the second step was usually over 90% by reanalysis.
A 3-hour "Cr release test was used to test the cytotoxicity of unseparated and separated effector cells after culture with rIL-2 plus LMW-BCGF. Targets were K562, Raji (Burkitt's lymphoma), and autologous leukemic blasts that were stored in liquid nitrogen and thawed before labeling. For the labeling of the target cells, 100 pCi "Cr was incubated with lo6 pelleted cells for 1 hour and then washed three times. Different effector-target ratios (E:T) were used. Cells were incubated in microculture wells in triplicate. After 3 hours of incubation, the supernatants were harvested and radioactivity was determined with a gamma counter. Cytotoxic activity was calculated by the following formula:
Cytotoxicity assay for different subsets.
Lytic units (LU) were calculated according to the formula of Pross et aLz8 One LU was defined as the number of cells needed to lyse 33% of the targets and calculated per lo7 effector cells. LU per culture were calculated using the total number of cells at the end of culture. Table 2) . No cell expansion in either total cell number or number of T cells was observed in cultures with rIL-2 alone in these five cases (data not shown). Lytic activity of unseparated cultured cells. Cells generated from five patients with active disease in culture with a combination of rIL-2 and LMW-BCGF were harvested directly on days 7 or 14 to determine their lytic activity against K562, Raji, and cryopreserved autologous blasts. All five cases expressed LAK activity against K562 and Raji cells, and four cases showed lytic activity against autologous leukemic blasts (Table 2) .
RESULTS
Generation
To compare the cytolytic activity of cells in culture with rIL-2 plus LMW-BCGF with those in culture with rIL-2 alone, cells from three samples of each culture were harvested on day 7, and their cytotoxicity against K562 assayed.
In addition to the absence of cell expansion in culture with rIL-2 alone, the cytotoxicity of these cells was much lower than that of cells in culture with rIL-2 plus LMW-BCGF. No lytic activity against K562 was detected in culture with LMW-BCGF alone (Fig 1) .
Lytic activity of different subsets of generated cells. Generated cells in culture with rlL-2 plus LMW-BCGF from four cases (two with active disease, two in CR) were chosen for separation. Immunobeads and anti-CD3 and anti-Leu 19 antibodies were used in a two-step separation procedure to isolate these cells in three groups. Table 3 shows the cytotoxicity of three subsets against K562 and Raji on a per-cell basis. CD3-/Leu 19+ cells expressed the highest lytic activity against NK-sensitive K562 cells as well as NKresistant Raji cells. CD3+/Leu 19+ cells showed median cytotoxicity, and CD3 + /Leu 19 -cells mediated only minimal cytotoxic activity. LAK activity against both K562 and Raji in each subset of cells from patients in C R was higher than that of those with active disease, as shown in Table 3 . CD3-/Leu 19+ cells in two patients with active disease expressed lytic activity against autologous leukemic blasts, while no cytotoxicity was detected in either CD3 + /Leu 19-or CD3+/Leu 19+ subsets.
In addition to a comparison of different subsets of cells, the cytotoxicity of fresh BM cells and unseparated cells that had been generated from the same sample were also tested in Cytotoxicity is expressed as lytic units of specific 5'Cr release from labeled target cells, using a 3-hour assay. In this study we investigated the antigenic phenotype and lytic characteristics of LAK cells generated from the BM cells of children with ALL after culture of these cells with LMW-BCGF plus rIL-2. We found that cultures from all patients studied generated primarily CD3 + /Leu 19 -cells. 
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